drugset / Trial / NCT00407264
Randomized Trial of Fluticasone in Bronchial Premalignancy
Phase 2
Completed
90 enrolled
Amsterdam UMC, location VUmc
GlaxoSmithKline · collabThe Netherlands Cancer Institute · collab
RandomizedCrossoverDouble-blindPrevention
Summary
The purpose of this study is to assess the efficacy of fluticasone on the development of lung cancer in smokers
Timeline
- Start
- 2002-02
- Primary completion
- —
- Completion
- 2005-12
Publications
- Background Wattenberg LW, Wiedmann TS, Estensen RD, Zimmerman CL, Galbraith AR, Steele VE, Kelloff GJ. Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol. Carcinogenesis. 2000 Feb;21(2):179-82. doi: 10.1093/carcin/21.2.179.
- Background Breuer RH, Snijders PJ, Sutedja TG, v d Linden H, Risse EK, Meijer CJ, Postmus PE, Smit EF. Suprabasal p53 immunostaining in premalignant endobronchial lesions in combination with histology is associated with bronchial cancer. Lung Cancer. 2003 May;40(2):165-72. doi: 10.1016/s0169-5002(03)00029-1.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone propionate | Other / unclassified | 500 ug | Inhaled |